IMEIK
IMEIK
IMEIK is a leading Chinese biomedical soft tissue repair materials manufacturer.
IMEIK, founded in 2004, has been developed based on the research, development, and transformation of biomedical soft tissue repair materials. The founder is Jian Jun. Listed on the Shanghai Stock Exchange in September 2020, the company's major shareholders are Jian Jun, Ningbo Zhixingjun Investment Management Limited Partnership, and GANNETT PEAK LIMITED. Rivals with the direct and indirect competition with IMEIK include Haohai Biological, Bloomage BioTech.
- All
- News
- Analysis
- Research
In-depth
Healthcare
China VC Investment List Q4 2022 – Healthcare
For healthcare, we at EqualOcean have identified 20 companies worth watching in Q4 identified by proceedings. We select venture capital investments of over CNY 200 million on average or the equivalent value in USD in a single round.
Jan 05, 2023 06:55 PM
Briefing May 23, 2022 12:38 PM
· Healthcare
Aimeike signs distribution cooperation framework agreement with South Korea huons BP
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Feb 25, 2022 09:58 AM
· Healthcare
The steel sector strengthened significantly
Briefing Dec 09, 2021 10:39 AM
Baijiu plate strength, mouth cellar line exceeds 10%
Briefing Oct 22, 2021 10:13 PM
· Real Estate
AMEC: the capital increase and acquisition of part of the equity of hoons biopharma in South Korea have been completed
Healthcare
SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year
EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.
Jun 06, 2024 06:18 PM
Healthcare
Cellatopia Secures Nearly CNY Ten Mn in Seed Funding
EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).
Apr 18, 2024 01:25 PM
Briefing Oct 19, 2021 06:56 AM
· Financials
The investment banking business was strictly supervised, and seven securities companies received fines
Briefing Oct 17, 2021 06:26 PM
· Healthcare
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Briefing Sep 24, 2021 11:28 AM
· Healthcare
The medical and American plate rose sharply
Briefing Aug 23, 2021 07:46 PM
· Healthcare
AMEC: the net profit in the first half of the year was 425 million yuan, a year-on-year increase of 188.86%
Briefing Jul 08, 2021 07:41 PM
· Financials
Aimike's reply to the letter of concern: after obtaining the equity of huons bio, it will not have a significant adverse impact on the company's production and operation
See more
Related Companies
